Advisors Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.6M Sell
22,367
-360
-2% -$365K 0.34% 47
2025
Q4
$24.4M Sell
22,727
-944
-4% -$903K 0.41% 33
2025
Q3
$18.1M Sell
23,671
-425
-2% -$316K 0.31% 51
2025
Q2
$18.8M Sell
24,096
-2,016
-8% -$1.57M 0.34% 44
2025
Q1
$21.6M Sell
26,112
-5,261
-17% -$4.38M 0.41% 33
2024
Q4
$24.2M Sell
31,373
-9,559
-23% -$7.91M 0.45% 31
2024
Q3
$36.3M Sell
40,932
-6,922
-14% -$6.22M 0.67% 16
2024
Q2
$43.3M Sell
47,854
-11,009
-19% -$8.81M 0.85% 11
2024
Q1
$45.8M Sell
58,863
-8,636
-13% -$6.15M 0.88% 11
2023
Q4
$39.3M Sell
67,499
-8,116
-11% -$4.74M 0.8% 11
2023
Q3
$40.6M Buy
75,615
+601
+0.8% +$310K 0.88% 14
2023
Q2
$35.2M Sell
75,014
-3,875
-5% -$1.63M 0.72% 17
2023
Q1
$27.1M Buy
78,889
+819
+1% +$276K 0.55% 30
2022
Q4
$28.6M Sell
78,070
-11,086
-12% -$3.93M 0.59% 25
2022
Q3
$28.8M Sell
89,156
-199
-0.2% -$63K 0.61% 22
2022
Q2
$29M Sell
89,355
-7,049
-7% -$2.12M 0.55% 27
2022
Q1
$27.6M Sell
96,404
-4,771
-5% -$1.23M 0.43% 37
2021
Q4
$27.9M Buy
101,175
+920
+0.9% +$233K 0.4% 41
2021
Q3
$23.2M Sell
100,255
-112
-0.1% -$27.6K 0.35% 47
2021
Q2
$23M Sell
100,367
-6,872
-6% -$1.38M 0.34% 48
2021
Q1
$20M Buy
107,239
+8,077
+8% +$1.58M 0.31% 53
2020
Q4
$16.7M Buy
99,162
+6,686
+7% +$998K 0.28% 58
2020
Q3
$13.7M Sell
92,476
-813
-0.9% -$126K 0.25% 68
2020
Q2
$15.3M Buy
93,289
+4,415
+5% +$678K 0.3% 61
2020
Q1
$12.3M Buy
88,874
+5,410
+6% +$743K 0.29% 68
2019
Q4
$11M Buy
83,464
+7,065
+9% +$819K 0.19% 122
2019
Q3
$8.54M Buy
76,399
+12,264
+19% +$1.37M 0.16% 160
2019
Q2
$7.11M Sell
64,135
-39,508
-38% -$4.65M 0.13% 194
2019
Q1
$13.4M Sell
103,643
-3,597
-3% -$437K 0.24% 94
2018
Q4
$12.4M Buy
107,240
+12,712
+13% +$1.42M 0.25% 94
2018
Q3
$10.1M Sell
94,528
-461
-0.5% -$46.1K 0.17% 149
2018
Q2
$8.11M Sell
94,989
-21,642
-19% -$1.78M 0.14% 180
2018
Q1
$8.98M Sell
116,631
-7,988
-6% -$643K 0.15% 164
2017
Q4
$10.5M Sell
124,619
-6,680
-5% -$568K 0.17% 152
2017
Q3
$11.2M Sell
131,299
-71,760
-35% -$5.89M 0.19% 136
2017
Q2
$16.7M Sell
203,059
-52,623
-21% -$4.29M 0.28% 81
2017
Q1
$21.5M Buy
255,682
+17,586
+7% +$1.41M 0.36% 51
2016
Q4
$17.5M Buy
238,096
+32,792
+16% +$2.44M 0.29% 74
2016
Q3
$16.5M Buy
205,304
+13,085
+7% +$1.05M 0.27% 82
2016
Q2
$15.1M Buy
192,219
+27,776
+17% +$2.09M 0.25% 97
2016
Q1
$11.8M Buy
164,443
+8,997
+6% +$681K 0.2% 135
2015
Q4
$13.1M Sell
155,446
-174,868
-53% -$14.5M 0.21% 119
2015
Q3
$27.6M Sell
330,314
-167,462
-34% -$14.1M 0.44% 31
2015
Q2
$41.6M Sell
497,776
-169,696
-25% -$12.9M 0.57% 15
2015
Q1
$48.5M Sell
667,472
-159,353
-19% -$11.3M 0.65% 15
2014
Q4
$57M Sell
826,825
-63,360
-7% -$4.28M 0.76% 9
2014
Q3
$57.7M Buy
890,185
+29,947
+3% +$1.9M 0.8% 8
2014
Q2
$53.5M Buy
860,238
+35,131
+4% +$2.1M 0.74% 10
2014
Q1
$48.6M Buy
825,107
+32,088
+4% +$1.79M 0.74% 10
2013
Q4
$40.4M Buy
793,019
+5,939
+0.8% +$297K 0.65% 17
2013
Q3
$39.6M Buy
787,080
+4,647
+0.6% +$243K 0.7% 17
2013
Q2
$38.4M Buy
+782,433
New +$42.6M 0.73% 11

Other funds holding LLY

Advisors Asset Management's LLY Position: Q1 2026 in Review

Advisors Asset Management reduced its Eli Lilly (LLY) stake by 1.6% in Q1 2026, selling an estimated $365K and leaving 22,367 shares worth $20.6M. The position accounts for 0.34% of the portfolio, ranked #47.

Advisors Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.7M in Q3 2014. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Advisors Asset Management held 22,367 shares of Eli Lilly worth $20.6M as of Q1 2026.
  • Advisors Asset Management sold 360 Eli Lilly shares in Q1 2026, an estimated $365K.
  • Eli Lilly made up 0.34% of Advisors Asset Management's portfolio in Q1 2026, its #47 holding.
  • Advisors Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Advisors Asset Management's Eli Lilly position peaked at $57.7M in Q3 2014.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.